Reduced tumor stiffness quantified by tomoelastography as a predicative marker for glypican-3-positive hepatocellular carcinoma

BACKGROUND: Glypican-3 (GPC3) expression is investigated as a promising target for tumor-specific immunotherapy of hepatocellular carcinoma (HCC). This study aims to determine whether GPC3 alters the viscoelastic properties of HCC and whether tomoelastography, a multifrequency magnetic resonance ela...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Yihuan, Guo, Jing, Ma, Di, Zhou, Jiahao, Yang, Yuchen, Chen, Yongjun, Wang, Huafeng, Sack, Ingolf, Li, Ruokun, Yan, Fuhua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9744252/
https://www.ncbi.nlm.nih.gov/pubmed/36518314
http://dx.doi.org/10.3389/fonc.2022.962272

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9744252/
https://www.ncbi.nlm.nih.gov/pubmed/36518314
http://dx.doi.org/10.3389/fonc.2022.962272

Ejemplares similares